|
|
|
St. Louis, Missouri (Cherokee)
 Site Overview SAFC's St. Louis, Missouri (USA) campus is a key center of manufacturing excellence in cGMP biologics, with over 25 years experience in plant- and animal-based therapeutic protein extraction and purification, bio-conjugation, excipients and adjuvants manufacturing. In addition, SAFC® St Louis works in close alignment with SAFC's Madison high-potency API (HPAPI) manufacturing operations to create Antibody Drug Conjugates.
| Core Technologies |
Core Competencies |
| High-Potent and Non-Potent Conjugation |
Animal-sourced API manufacturing |
| Biologics extraction & Purification |
Plant-sourced API manufacturing |
| |
Bio-Organic API Synthesis and Purification |
| |
Antibody Drug Conjugates |
| |
Excipients and adjuvants |
| |
Transgenic-sourced products |
| Capabilities/Equipment Overview |
| Safebridge® certified Dedicated suite for High Potent compound handling up to category IV |
| Completely segregated plant and animal protein processing facilities eliminates potential cross-contamination |
| A large-scale extraction and clarification facility that is capable of processing multi-ton quantities of biomass per day |
| Large Class 100,000 (ISO 8) and Class 10,000 (ISO 7) Clean Rooms capable of handling up to one meter chromatography operations |
| Bulk API Lyophilization and packaging operations |
| Extensive analytical capabilities and dedicated compliance |
St. Louis (Cherokee) Virtual Tour
Certificates and Documents
| US FDA Registered Facility – Registration Number 1937990 |
Contact St. Louis (Cherokee)
3300 South Second St.
St. Louis, MO 63118
USA
Tel: (314) 286-6689
Tel: (800) 244-1173
Schedule a Site Audit
Request Quality Information
|
|
